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Background
B lymphocytes of patients with chronic HIV-1 infection
(CHI) show functional and phenotypic abnormalities. We
investigated the effects of primary HIV-1 infection (PHI)
on activation, differentiation and survival of B cells. The
effects of antiretroviral therapies on B cell dysfunctions in
PHI were also studied.
Design and Methods
B cells of 31 PHI patients (sampled at baseline, 1 month
and 6 months post therapy), 26 CHI patients, and 12
healthy donors were studied for surface expression of Fas,
LAIR-1, CD70, intracellular expression of Bcl-2, and spon-
taneous apoptosis. Four-colour FACS
(IgD+IgM+CD19+CD27), and short-term PBMC cultures
to analyse induction of CD25 on B cells were performed
in 5 PHI patients.
Results
In PHI, naïve and memory B lymphocytes were highly
activated, manifested by hypergammaglobulinemia,
altered expression of Fas and LAIR-1, and increased spon-
taneous apoptosis. Antiretroviral treatment improved the
activation/differentiation status of B cells, reduced apop-
tosis to levels comparable to healthy individuals and
restored the ability of B cells to respond to T-cell depend-
ent activation. B cells of PHI patients on HAART recovered
better compared to patients on RTI only. Data obtained
on 5 PHI patients at baseline showed decreased IgM+
memory B cells and lower induction of CD25 expression
on B cells upon T cell activation. These parameters were
normalized after 6 months of antiretroviral treatment.
Conclusion
B cell dysfunctions in HIV-1 infection appear during pri-
mary infection and initiation of antiretroviral therapy
early during infection may help preserve the B cell com-
partment.
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